浏览全部资源
扫码关注微信
聚ADP-核糖聚合酶-1在喉鳞状细胞癌细胞DNA氧化损伤及凋亡中的作用
The role of poly ADP-ribose polymerase-1 in oxidative DNA damage and apoptosis of laryngeal squamous cell carcinoma cells
- 局解手术学杂志 2023年32卷第8期 页码：666-672
- 作者机构：
1.新疆医科大学第一附属医院肿瘤中心，新疆 乌鲁木齐 830011
2.新疆医科大学第一附属医院耳鼻喉科，新疆 乌鲁木齐 830011
- 作者简介：
赵化荣，E-mail：xydyfyzhr@163.com
- 基金信息：国家重点实验室开放课题(SKL-HIDCA-2021-6)
DOI：10.11659/jjssx.08E022029
中图分类号： R739.8纸质出版日期：2023-08-25，
收稿日期：2022-08-04，
扫 描 看 全 文
宿伟鹏,赵化荣,刘攀等.聚ADP-核糖聚合酶-1在喉鳞状细胞癌细胞DNA氧化损伤及凋亡中的作用[J].局解手术学杂志,2023,32(08):666-672.
SU Wei-peng,ZHAO Hua-rong,LIU Pan,et al.The role of poly ADP-ribose polymerase-1 in oxidative DNA damage and apoptosis of laryngeal squamous cell carcinoma cells[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(08):666-672.
宿伟鹏,赵化荣,刘攀等.聚ADP-核糖聚合酶-1在喉鳞状细胞癌细胞DNA氧化损伤及凋亡中的作用[J].局解手术学杂志,2023,32(08):666-672. DOI： 10.11659/jjssx.08E022029.
SU Wei-peng,ZHAO Hua-rong,LIU Pan,et al.The role of poly ADP-ribose polymerase-1 in oxidative DNA damage and apoptosis of laryngeal squamous cell carcinoma cells[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(08):666-672. DOI： 10.11659/jjssx.08E022029.
摘要
目的
2
探究聚ADP-核糖聚合酶-1（PARP1）在喉鳞状细胞癌（LSCC）中的表达及其对LSCC细胞DNA氧化损伤与凋亡的影响。
方法
2
收集40例患者的LSCC组织及癌旁组织样本，采用免疫组化染色和qRT-PCR检测LSCC组织与癌旁组织中PARP1的表达。采用不同浓度Menadione诱导LSCC细胞系Hep-2，MTT法检测不同浓度诱导下细胞增殖抑制率。将Hep-2细胞随机分为对照组（正常培养）、Men组（20 μmol/L Menadione处理）、Men+PARP1抑制剂组（20 μmol/L Menadione+10 μmol/L PARP1抑制剂Olaparib共处理）。MTT法计算各组细胞增殖抑制率；流式细胞术检测各组细胞内活性氧（ROS）水平；细胞免疫荧光染色观察各组细胞DNA损伤标记分子γ-H2AX焦点生成情况；Western blot测定各组细胞γ-H2AX、DNA-PKcs、BRCA1、LIG4、Caspase-3及Caspase-9蛋白表达；Hoechst33258染色观察各组细胞凋亡情况。
结果
2
LSCC组织中PARP1阳性表达率及PARP1 mRNA表达均明显高于癌旁组织（
P
<
0.01）。Hep-2细胞经不同浓度Menadione诱导后，细胞增殖抑制率均升高（
P
<
0.05）。与对照组比较，Men组和Men+PARP1抑制剂组的细胞增殖抑制率升高，细胞ROS水平升高，γ-H2AX焦点形成明显增加，γ-H2AX蛋白表达上调，DNA-PKcs、BRCA1、LIG4蛋白表达均下调，细胞出现浓缩、碎裂的蓝色凋亡体，Caspase-3和Caspase-9蛋白表达上调，差异均有统计学意义（
P
<
0.05），且Men+PARP1抑制剂组以上变化较Men组更明显（
P
<
0.05）。
结论
2
PARP1在LSCC组织中高表达，抑制其表达能够进一步加重Menadione诱导的Hep-2细胞DNA氧化损伤，并促进细胞凋亡。
Abstract
Objective
2
To investigate the expression of poly ADP-ribose polymerase-1 （PARP1） in laryngeal squamous cell carcinoma （LSCC） and its effect on DNA oxidative damage and apoptosis of LSCC cells.
Methods
2
LSCC tissue and paracancerous tissue samples from 40 patients were collected. Immunohistochemical staining and qRT-PCR were used to detect the expression of PARP1 in LSCC tissue and paracancerous tissue. LSCC cell line Hep-2 was induced by different concentrations of Menadione， and the inhibition rate of cell proliferation was detected by MTT assay. The Hep-2 cells were randomly divided into the control group（normal culture）， Men group （treated with 20 μmol/L Menadione）， Men+PARP1 inhibitor group （co-treated with 20 μmol/L Menadione and 10 μmol/L PARP-1 inhibitor Olaparib）， the inhibition rate of cell proliferation was calculated by MTT assay， the intracellular reactive oxygen species （ROS） levels in each group was detected by flow cytometry， the focus formation of DNA damage marker γ-H2AX in each group was observed by immunofluorescence staining， the protein expression of γ-H2AX， DNA-PKcs， BRCA1， LIG4， Caspase-3 and Caspase-9 in each group were determined by Western blot， the apoptosis in each group was observed by Hoechst33258 staining.
Results
2
The positive expression rate of PARP1 and the relative expression of PARP1 mRNA in LSCC tissues were significantly higher than those in paracancerous tissue （
P
<
0.01）. The proliferation inhibition rates of Hep-2 cells after induced by different concentration of Menadione were increased （
P
<
0.05）.Compared with the control group， the inhibition rates of cell proliferation in the Men group and the Men+PARP1 inhibitor group were increased， the levels of ROS were increased， the formations of γ-H2AX foci were significantly increased， and the relative protein expression of γ-H2AX protein were up-regulated， the relative protein expression of DNA-PKcs， BRCA1 and LIG4 were all down-regulated， the cells appeared condensed and fragmented blue apoptotic bodies appeared in cells， the relative protein expression of Caspase-3 and Caspase-9 were down-regulated， the differences were statistically significant （
P
<
0.05）； and the above changes were more significant in the Men+PARP1 inhibitor group than in the Men group （
P
<
0.05）.
Conclusion
2
PARP1 is highly expressed in LSCC tissue， which can further aggravate Menadione-induced DNA oxidative damage of Hep-2 cells and promote apoptosis after inhibited.
关键词
喉鳞状细胞癌聚ADP-核糖聚合酶-1DNA氧化损伤凋亡
Keywords
laryngeal squamous cell carcinomapoly ADP-ribose polymerase-1DNA oxidative damageapoptosis
references
Bray F，Ferlay J，Soerjomataram I，et al.Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin，2018，68（6）：394-424.doi：10.3322/caac.21492http://dx.doi.org/10.3322/caac.21492.
Steuer CE，El-Deiry M，Parks JR，et al.An update on larynx cancer［J］.CA Cancer J Clin，2017，67（1）：31-50.doi：10.3322/caac.21386http://dx.doi.org/10.3322/caac.21386.
Farlow JL，Brenner JC，Lei YL，et al.Immune deserts in head and neck squamous cell carcinoma：a review of challenges and opportunities for modulating the tumor immune microenvironment［J］.Oral Oncol，2021，120：105420.doi：10.1016/j.oraloncologyhttp://dx.doi.org/10.1016/j.oraloncology.
Siegel RL，Miller KD，Fuchs HE，et al.Cancer Statistics，2021［J］.CA Cancer J Clin，2021，71（1）：7-33.doi：10.3322/caac.21654http://dx.doi.org/10.3322/caac.21654.
Kim C，Chen C，Yu Y.Avoid the trap：targeting PARP1 beyond human malignancy［J］.Cell Chem Biol，2021，28（4）：456-462.doi：10.1016/j.chembiol.2021.02.004http://dx.doi.org/10.1016/j.chembiol.2021.02.004.
Ray Chaudhuri A，Nussenzweig A.The multifaceted roles of PARP1 in DNA repair and chromatin remodelling［J］.Nat Rev Mol Cell Biol，2017，18（10）：610-621.doi：10.1038/nrm.2017.53http://dx.doi.org/10.1038/nrm.2017.53.
Kontandreopoulou CN，Diamantopoulos PT，Tiblalexi D，et al.PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome［J］.Blood Adv，2021，5（22）：4794-4805.doi：10.1182/bloodadvances.2021004638http://dx.doi.org/10.1182/bloodadvances.2021004638.
Zhang X，Wang Y，A GR，et al.Pan-cancer analysis of PARP1 alterations as biomarkers in the prediction of immunotherapeutic effects and the association of its expression levels and immunotherapy signatures［J］.Front Immunol，2021，12：721030.doi：10.3389/fimmu.2021.721030http://dx.doi.org/10.3389/fimmu.2021.721030.
Rajawat J，Shukla N，Mishra DP.Therapeutic targeting of poly（ADP-ribose） polymerase-1 （PARP1） in cancer：current developments，therapeutic strategies，and future opportunities［J］.Med Res Rev，2017，37（6）：1461-1491.doi：10.1002/med.21442http://dx.doi.org/10.1002/med.21442.
Manchana T，Phoolcharoen N，Tantbirojn P.BRCA mutation in high grade epithelial ovarian cancers［J］.Gynecol Oncol Rep，2019，29：102-105.doi：10.1016/j.gore.2019.07.007http://dx.doi.org/10.1016/j.gore.2019.07.007.
Tumban E.A current update on human papilloma virus-associated head and neck cancers［J］.Viruses，2019，11（10）：922.doi：10.3390/v11100922http://dx.doi.org/10.3390/v11100922.
Ji X，Sui L，Song K，et al.PD-L1，PARP1，and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer［J］.Cancer Med，2021，10（14）：4743-4751.doi：10.1002/cam4.4034http://dx.doi.org/10.1002/cam4.4034.
Dutta P，Paico K，Gomez G，et al.Transcriptional regulation of CL2 by PARP1 is a driver for invasiveness in breast cancer［J］.Cancers （Basel），2020，12（5）：1317.doi：10.3390/cancers12051317http://dx.doi.org/10.3390/cancers12051317.
Kupczyk P，Simiczyjew A，Marczuk J，et al.PARP1 as a marker of an aggressive clinical phenotype in cutaneous melanoma：a clinical and an in vitro study［J］.Cells，2021，10（2）：286.doi：10.3390/cells10020286http://dx.doi.org/10.3390/cells10020286.
de Almeida LC，Calil FA，Machado-Neto JA，et al.DNA damaging agents and DNA repair：from carcinogenesis to cancer therapy［J］.Cancer Genet，2021，252/253：6-24.doi：10.1016/j.cancergen.2020.12.002http://dx.doi.org/10.1016/j.cancergen.2020.12.002.
Majiene D，Kuseliauskyte J，Stimbirys A，et al.Comparison of the effect of native 1，4-Naphthoquinones plumbagin，menadione，and lawsone on viability，Redox status，and mitochondrial functions of C6 glioblastoma cells［J］.Nutrients，2019，11（6）：1294.doi：10.3390/nu11061294http://dx.doi.org/10.3390/nu11061294.
Fong PC，Boss DS，Yap TA，et al.Inhibition of poly（ADP-ribose） polymerase in tumors from BRCA mutation carriers［J］.N Engl J Med，2009，361（2）：123-134.doi：10.1056/NEJMoa0900212http://dx.doi.org/10.1056/NEJMoa0900212.
Noubissi FK，McBride AA，Leppert HG，et al.Detection and quantification of γ-H2AX using a dissociation enhanced lanthanide fluorescence immunoassay［J］.Sci Rep，2021，11（1）：8945.doi：10.1038/s41598-021-88296-3http://dx.doi.org/10.1038/s41598-021-88296-3.
王丽娜，罗志，张立.DNA损伤及其标志物γ-H2AX检测的研究进展［J］.分析试验室，2020，39（10）：1131-1136.doi：10.13595/j.cnki.issn1000-0720.2020.060402http://dx.doi.org/10.13595/j.cnki.issn1000-0720.2020.060402.
Yang H，Yao F，Marti TM，et al.Beyond DNA repair：DNA-PKcs in tumor metastasis，metabolism and immunity［J］.Cancers （Basel），2020，12（11）：3389.doi：10.3390/cancers12113389http://dx.doi.org/10.3390/cancers12113389.
Martinez AR，Kaul Z，Parvin JD，et al.Differential requirements for DNA repair proteins in immortalized cell lines using alternative lengthening of telomere mechanisms［J］.Genes Chromosomes Cancer，2017，56（8）：617-631.doi：10.1002/gcc.22465http://dx.doi.org/10.1002/gcc.22465.
Cartwright IM，Liu X，Zhou M，et al.Essential roles of Caspase-3 in facilitating Myc-induced genetic instability and carcinogenesis［J］.Elife，2017，6：e26371.doi：10.7554/eLife.26371http://dx.doi.org/10.7554/eLife.26371.
Zhang J，Kodali S，Chen M，et al.Maintenance of germinal center B cells by Caspase-9 through promotion of apoptosis and inhibition of necroptosis［J］.J Immunol，2020，205（1）：113-120.doi：10.4049/jimmunol.2000359http://dx.doi.org/10.4049/jimmunol.2000359.
0
浏览量
4
下载量
0
CSCD
- 网络PDF下载
- WORD下载
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
